Radical Numerics emerged from stealth with a $50 million seed round led by Emergence Capital, aiming to “read, write, and reason” in biology using AI across molecules rather than single modalities. The startup says prior research produced AI models capable of generating DNA at scale and helped enable the world’s first fully AI-designed functional virus using open-source weights. The investment underscores how AI toolchains are moving from lab demonstrations toward platform bets in drug discovery and systems biology.